Tatva Chintan Pharma Chem Limited / Fundamentals

    Income statement

    Net revenue
    €37.48M
    Cost of goods sold
    €21.38M
    Gross profit
    €16.10M
    SG&A expenses
    €1.83M
    R&D expenses
    €0.00
    EBITDA
    €3.47M
    D&A
    €2.68M
    EBIT
    €4.01M
    Interest expenses
    €126.34K
    EBT
    €742.36K
    Tax expenses
    €182.85K
    Net income
    €559.51K

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    -€559.51K
    Changes in working capital
    €0.00
    Operating cash flow
    €0.00
    Capex
    €0.00
    Other investing cash flow
    €0.00
    Net investing cash flow
    €0.00
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €0.00
    Debt repayment
    €0.00
    Other financing cash flow
    €0.00
    Net financing cash flow
    €0.00
    Foreign exchange effects
    €0.00
    Net change in cash
    €0.00
    Cash at end of period
    €0.00
    Free cash flow
    €0.00

    Balance sheet

    Cash and cash equivalents
    €1.38M
    Cash and short-term investments
    €1.38M
    Total receivables
    €8.08M
    Inventory
    €13.12M
    Other current assets
    €3.40M
    Total current assets
    €25.98M
    Property, plant & equipment
    €53.58M
    Goodwill
    €0.00
    Intangible assets
    €577.73K
    Long-term investments
    €0.00
    Other non-current assets
    €1.76M
    Total non-current assets
    €55.92M
    Total assets
    €81.90M
    Accounts payable
    €3.20M
    Short-term debt
    €3.56M
    Other current liabilities
    €2.64M
    Total current liabilities
    €9.40M
    Long-term debt
    €0.00
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €136.91K
    Total non-current liabilities
    €136.91K
    Total liabilities
    €9.54M
    Common stock
    €2.29M
    Retained earnings
    €0.00
    Other equity
    €70.07M
    Total equity
    €72.36M
    Total liabilities and shareholders' equity
    €81.90M

    Company information

    Market capitalization
    €217.55M
    Employees
    689
    Enterprise Value
    €21.66B

    Company ratios

    Gross margin
    43.0% Worse than peer group: 49.6%
    EBITDA margin
    9.3% Worse than peer group: 28.1%
    EBIT margin
    10.7% Worse than peer group: 22.8%
    EBT margin
    2.0% Much worse than peer group: 22.6%
    Net margin
    1.5% Worse than peer group: 16.9%
    ROE
    0.8% Worse than peer group: 18.4%
    ROA
    0.7% Worse than peer group: 11.2%
    Asset turnover
    45.8% Much worse than peer group: 72.6%
    FCF margin
    0.0%
    FCF yield
    0.0%
    Efficiency ratio
    90.7%
    Net sales per employee
    €54.40K
    Net income per employee
    €812.06

    Notifications